The expression of one of these proteins, Apolipoprotein CIII, was found to be reduced in the plasma from pancreatic cancer patients as compared to controls making it a potential marker for the early detection of this disease [42, 43]. The gene discussed is APOC3; the disease is familial pancreatic carcinoma.